Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Natalie Silliman

1-50 of 114 results

View this query on the Wikidata Query Service
The consensus coding sequences of human breast and colorectal cancers

scientific article
The genomic landscapes of human breast and colorectal cancers

scientific article
High frequency of mutations of the PIK3CA gene in human cancers

scientific article (publication date: 23 April 2004)
Detection and localization of surgically resectable cancers with a multi-analyte blood test.

scientific article published on 18 January 2018
Mutational analysis of the tyrosine phosphatome in colorectal cancers

scientific article
Colorectal cancer: mutations in a signalling pathway

scientific article published in August 2005
Mutational analysis of the tyrosine kinome in colorectal cancers

scientific article (publication date: 9 May 2003)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

scientific article
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

scientific article
Three classes of genes mutated in colorectal cancers with chromosomal instability

scientific article published in May 2004
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

scientific article published on 5 September 2017
Prevalence of somatic alterations in the colorectal cancer cell genome

scientific article
Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers

scientific article
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.

scientific article published in March 2018
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

scientific article published on 20 March 2018
Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer

scientific article published on 09 May 2019
Large-scale identification of novel transcripts in the human genome

scientific article published on 31 January 2007
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

scientific article published on 17 October 2019
Diagnostic potential of tumor DNA from ovarian cyst fluid

scientific article published on 15 July 2016
A multimodality test to guide the management of patients with a pancreatic cyst

scientific article published on 01 July 2019
Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

article
Assessing aneuploidy with repetitive element sequencing

scientific article published on 19 February 2020
Figure S6 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Supplemental Table 2 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S9 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S10 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Supplemental Table 1 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S7 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Figure S3 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Supplemental Table 2 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Supplemental Table 3 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Supplementary Data from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S1 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Supplementary Tables S1 and S2 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S1 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S6 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S8 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Figure S8 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

supplemental table 5 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Supplementary Notes 1-5 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Figure 3 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Supplementary Figures S1-S9 from Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM

Figure S7 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

Table 3 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S2 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

Figure S2 from A Blood-Based Assay for Detection of Patients with Advanced Adenomas

The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer

scientific article published on 11 August 2023
Figure S8 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Figure S4 from The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer

Supplementary Tables S1 to S6 from Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA

Paulina is supported by:

About Paulina

Help